Sort
39,280 grants matching “leukemia”
Post-transplant vaccines to enhance graft-versus-leukemia responses
$433,125Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · R01 · FY2012 · HL
Clinical Trials Evaluating Transplant Strategies and Adoptive Cell Therapies to
$433,106Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2015 · CA
Clinical Trials Evaluating Transplant Strategies and Adoptive Cell Therapies to
$433,106Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2013 · CA
Clinical Trials Evaluating Transplant Strategies and Adoptive Cell Therapies to
$433,106Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2016 · CA
THE BIOLOGY OF PROMYELOCYTIC LEUKEMIA IN A MOUSE MODEL.
$433,099Washington University · R01 · FY2004 · CA
Genetic Dissection of Trisomy 21
$433,098Eugene Yu · Roswell Park Cancer Institute Corp · R01 · FY2012 · HL
Project 2: Early crosstalk between HTLV-1 infected T cells and bone microenvironment
$433,069Deborah V Novack · Washington University · P01 · FY2025 · CA
Case-only Cancer Clustering for Mobile Populations
$433,039Geoffrey M. Jacquez · Biomedware · R44 · FY2009 · CA
Genomic and Genetic Dissection of Hematopoietic Development in Drosophila
$433,009Utpal Banerjee · University Of California Los Angeles · R01 · FY2023 · HL
MOLECULAR BIOLOGY OF MYELOID DIFFERENTIATION
$432,961Beth Israel Deaconess Medical Center · R01 · FY2004 · CA
Studies of other risk factors for radiosensitive tumors
$432,958Cari Kitahara · Division Of Cancer Epidemiology And Genetics · ZIA · FY2019 · CA
Drug Resistant Pathways in Relapsed Acute Lymphoblastic Leukemia(ALL)
$432,951William L. Carroll · New York University School Of Medicine · R01 · FY2015 · CA
Drug Resistant Pathways in Relapsed Acute Lymphoblastic Leukemia(ALL)
$432,951William L. Carroll · New York University School Of Medicine · R01 · FY2012 · CA
Tissue-specific tumor suppressor effects of p53
$432,908James J. Manfredi · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · CA
Murine Model for HIV-1 Replication
$432,879Salk Institute For Biological Studies · R01 · FY2001 · DA
Project 1. Regulation of Mast Cell Homeostasis in Type 2 Immunopathology
$432,834Joshua A Boyce · Brigham And Women'S Hospital · U19 · FY2024 · AI
Therapeutic Potential of Adaptive NK Cells in Cancer and Transplantation
$432,822Jeffrey S Miller · University Of Minnesota · P01 · FY2016 · CA
RAD51-dependent homologous recombination and thiopurine treatments for cancer
$432,761Michael D Wyatt · University Of South Carolina At Columbia · R15 · FY2018 · CA
Hematopoietic Regulation via GATA Switches
$432,719Emery H. Bresnick · University Of Wisconsin-Madison · R01 · FY2021 · DK
Molecular dissection of Hematopoietic Stem Cell specification triggered by inflammatory mediators
$432,679Raquel Espãn Palazãn · Iowa State University · R01 · FY2025 · DK
Project 1: Ionic Modulation of Chromatin in Cancer
$432,663Thomas V O'Halloran · Northwestern University At Chicago · U54 · FY2016 · CA
Exploting Zebrafish Models for Fanconi Anemia
$432,531John Harvey Postlethwait · Oregon Health & Science University · P01 · FY2010 · HL
DNA/RNA G-Quadruplexes: Structures, Transitions and Recognition
$432,516Dinshaw J Patel · Sloan-Kettering Inst Can Research · R01 · FY2010 · GM
Targeting protein acetylation as a therapeutic approach for MDS
$432,500Ling Li · Beckman Research Institute/City Of Hope · R01 · FY2019 · HL
Targeting protein acetylation as a therapeutic approach for MDS
$432,500Ling Li · Beckman Research Institute/City Of Hope · R01 · FY2020 · HL